Yi‐Chung Lee

Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

Vera Bril, Artur Drużdż, Julian Großkreutz et al. · The Lancet Neurology · 2023 · 227 citations

Clinical Trials, Generalised Myasthenia Gravis, Pharmacotherapy +3

Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

David Adams, Michael Polydefkis, Alejandra González‐Duarte et al. · The Lancet Neurology · 2020 · 154 citations · Full text

Alzheimer's Disease, Open-label Extension Study, Medicine +5

Cutoff Scores of the Cognitive Abilities Screening Instrument, Chinese Version in Screening of Dementia

Ker-Neng Lin, Pei‐Ning Wang, Chia Liu et al. · Dementia and Geriatric Cognitive Disorders · 2002 · 153 citations

Mutations in <i>KCND3</i> cause spinocerebellar ataxia type 22

Yi‐Chung Lee, Alexandra Dürr, Karen Majczenko et al. · Annals of Neurology · 2012 · 151 citations · Full text

Exercise training provides cardioprotection against ischemia–reperfusion induced apoptosis in young and old animals

John C. Quindry, J.M. French, Karen Hamilton et al. · Experimental Gerontology · 2005 · 130 citations

Physical Activity, Kinesiology, Cardiovascular Disease +14